Obesity Clinical Trial
Official title:
Influence of the Constancy of Daily Meal Pattern on Energy Balance, Glucose Profiles an Appetite in Healthy Women
In this study we will compare the health effect of two different meal patterns. In one subjects will consume food according to an 'irregular meal pattern' (3-9 meals/day) and the other 'regular meal pattern' (6 meals/day) for two weeks. The energy requirement of the subjects will be calculated to maintain body weight during the study. Participants will be provided with all the food to be consumed during the study. Initially, subjects will attend a screening visit in which they will complete questionnaires on medical health, eating habits and physical activity. Height, weight and waist circumference will be measured at this visit. Thereafter, subjects will be assigned to a 2-wk period following one of the two meal-patterns. There will be a 2-week period between the two interventions when subjects will consume their normal diet and at the end of this, participants will undertake the next meal pattern. During the two phases participants will be asked to wear an armband, which detects movement and measures heat loss, to assess their energy expenditure and a blood glucose monitoring device will be worn for three days. Before and after each 2-week intervention, subjects will come to the lab and will be given a test drink and blood samples will be obtained to evaluate the health effects of the meal patterns. Energy expenditure will be measured by indirect calorimetry. They will then be offered an ad-libitum meal and be asked to eat until they feel comfortably full. During each of the 2-week periods, participants will be asked to record their food intake and record their appetite sensations on specific days.
Background:
Previous work in our laboratory has shown that there are potentially important negative
health consequences associated with irregular eating. Greater fasting levels of
total-cholesterol and LDL-cholesterol, a decrease in meal induced thermogenesis, and as a
greater insulin response to a test drink, were observed in healthy women following a two-week
period of irregular meal pattern (variable number of daily meals; from 3 to 9); this was in
contrast to a regular pattern of six daily meals. In addition a greater energy intake was
self-reported during irregular compared with the regular meal pattern. Subsequent studies
have confirmed such an effect in overweight subjects and also provided evidence of
alterations in subjective appetite which may influence ad-libitum food intake. The present
project will study normal weight subjects, and incorporate energy expenditure measurement
under free living conditions using a novel technique (SenseWear armband, SWA), continuous
glucose monitor, and obtain more detailed information about appetite and food intake.
Aims:
To investigate the effects of regular and irregular meal pattern on energy expenditure,
energy intake, , Glucose profiles and subjective appetite in healthy normal weight women.
Experimental protocol and methods:
Normal weight women (BMI 18.5-25) who are otherwise healthy will be studied during the early
phase of their menstrual cycle (first week).
Subjects will be initially screened and then complete a 7 days food diary before
participating in the study which will last for a total of 6 weeks. During the first 2 weeks
participants will adopt one of two meal patterns, followed by a two-week washout period on
habitual diet and meal pattern, before undertaking a second 2-week intervention following the
second meal pattern. The meal patterns will be 1) regular - 6 daily meals or snacks for 2
weeks, or 2) irregular - a different number (between 3 and 9) of meals/snacks every day. All
foods to be consumed during weeks1, 2, 5 and 6 will be provided free of charge, and will
comprise foods commonly consumed in the British diet in amounts designed to keep body weight
constant during the study. Participants will complete food diaries over the study period.
Subjects will wear a SenseWare device (attached to an upper arm) to allow physical activity
and energy expenditure to be estimated in weeks1, 2, 5 and 6. Subjects will attend the lab on
the 6th day of each intervention phase to have a continuous glucose monitoring probe inserted
in their subcutaneous tissue over the abdomen and attached to a small monitor. Subjects will
also need to measure their blood glucose four times a day using a fingerprick to obtain a
droplet of blood and analysing it with a pocket glucose analyser. After three seven subjects
will be asked to come back to have the device removed.
Subjective appetite (hunger, fullness, etc.) will be assessed using visual analogue scales
(VAS) during the intervention (at the end of the first and second week) Before and after each
intervention period, participants will visit the laboratory after fasting overnight. At 8:30
am a cannula will be inserted into a hand vein, with the hand placed in a heating box, for
subsequent blood sampling. Indirect calorimetry will be performed to determine energy and
changes in the thermic response to a milkshake test drink providing 10 kcals/kg body weight,
and comprising 35% of energy as fat, 15% as protein, and 50% as carbohydrate. The SWA will be
placed on the upper left arm to estimate energy expenditure. Subsequent blood samples will be
obtained every 15 minutes during the next 3 hours in which indirect calorimetry and SWA will
be measured concurrently. Fasting blood samples will be used to measure total-, high density
lipoprotein (HDL)-, and low density lipoprotein (LDL)-cholesterol, triglycerides, glucose and
insulin. Blood samples obtained after the test drink will used to measure glucose, insulin
and hormones related to appetite. After that, a test meal (pasta) will be provided as
ad-libitum meal and subject will be asked to fill VAS to assess subjective appetite
sensations.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |